ZyCov-D
- Ministry of Science & Technology
DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials
The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs…
Read More » - India
Status of Development of COVID Vaccine in India
While the Govt. and Industry are trying their best to make available a safe and effective vaccine for COVID-19 at…
Read More » - Technology
Department of Biotechnology supported COVID 19 Vaccine -ZyCoV-D, designed and developed by Zydus,begins Adaptive Phase I/II clinical trials
Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the National Biopharma Mission, implemented by BIRAC…
Read More » - Technology
Indigenous Indian COVID19 vaccines in the global race to end the pandemic –By: Dr TV Venkateswaran
With the announcement of COVAXIN by Bharat Biotech and ZyCov-D Vaccine by Zydus Cadila the proverbial silver line in the…
Read More »